JENNIFER BRUMBACH: Open Payments
NPI 1518729730 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 29 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,436 · 2025 $783
Food & beverage: $597Education: $186
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $165 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $103 |
| Incyte Corporation | 1 | $100 |
| Janssen Biotech, Inc. | 1 | $86 |
| ABBVIE INC. | 4 | $82 |
| Novo Nordisk Inc | 5 | $75 |
| Lilly USA, LLC | 4 | $64 |
| PFIZER INC. | 2 | $42 |
| Exact Sciences Corporation | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: Kerendia, CAPLYTA, DARZALEX, MOUNJARO, UBRELVY, Ozempic, ELIQUIS, VRAYLAR.
Industry payments across TN — which companies pay providers there.
